Literature DB >> 25542852

Circulating tumor cell enumeration by the CellSearch system: the clinician's guide to breast cancer treatment?

Nick Beije1, Agnes Jager2, Stefan Sleijfer3.   

Abstract

Circulating tumor cells (CTCs) are cancer cells that are present in the blood of patients with solid cancers and are shed from existing tumor lesions into the blood stream. The enumeration of CTCs has long been considered to hold great promise in guiding treatment decision-making in breast cancer patients. However, guidelines on how to use CTC enumeration in clinical decision-making in primary breast cancer and metastatic breast cancer are lacking. Here, we set out to review the most relevant literature to date, to ultimately come to general recommendations regarding the use of CTC enumeration in primary breast cancer and metastatic breast cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; CTC; Circulating tumor cells; Clinical decision-making; Recommendations

Mesh:

Substances:

Year:  2014        PMID: 25542852     DOI: 10.1016/j.ctrv.2014.12.008

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  25 in total

1.  Health policy: Affordability of drugs used in oncology health care.

Authors:  Stefan Sleijfer; Jaap Verweij
Journal:  Nat Rev Clin Oncol       Date:  2016-05-10       Impact factor: 66.675

Review 2.  Clinical and biological significance of circulating tumor cells in cancer.

Authors:  Takaaki Masuda; Naoki Hayashi; Tomohiro Iguchi; Shuhei Ito; Hidetoshi Eguchi; Koshi Mimori
Journal:  Mol Oncol       Date:  2016-02-10       Impact factor: 6.603

Review 3.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

4.  Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.

Authors:  Christin Gasch; Theresa Oldopp; Oliver Mauermann; Tobias M Gorges; Antje Andreas; Cornelia Coith; Volkmar Müller; Tanja Fehm; Wolfgang Janni; Klaus Pantel; Sabine Riethdorf
Journal:  Mol Oncol       Date:  2016-07-22       Impact factor: 6.603

Review 5.  The Contribution of Angiogenesis to the Process of Metastasis.

Authors:  Diane R Bielenberg; Bruce R Zetter
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

Review 6.  Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer.

Authors:  Fariz Nurwidya; Jamal Zaini; Andika Chandra Putra; Sita Andarini; Achmad Hudoyo; Elisna Syahruddin; Faisal Yunus
Journal:  Chonnam Med J       Date:  2016-09-23

Review 7.  Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.

Authors:  Jennifer E Hardingham; Phulwinder Grover; Marnie Winter; Peter J Hewett; Timothy J Price; Benjamin Thierry
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 8.  Recent advances in the biology of human circulating tumour cells and metastasis.

Authors:  Sofia Gkountela; Barbara Szczerba; Cinzia Donato; Nicola Aceto
Journal:  ESMO Open       Date:  2016-08-03

9.  Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.

Authors:  Arun Satelli; Izhar Singh Batth; Zachary Brownlee; Christina Rojas; Qing H Meng; Scott Kopetz; Shulin Li
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

Review 10.  Stem-like features of cancer cells on their way to metastasis.

Authors:  Sofia Gkountela; Nicola Aceto
Journal:  Biol Direct       Date:  2016-07-26       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.